Semax Reconstitution Chart (Every Vial Size)

Overview of Semax Reconstitution in Preclinical Research

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic analogue of adrenocorticotropic hormone (ACTH 4-10) developed for in vitro and animal laboratory investigation. Delivered as a lyophilized powder to preserve stability, the compound requires precise solvent reconstitution prior to introduction into culture media, enzymatic assays, or animal models. Laboratory protocols demand meticulous calculations to ensure that volumetric deliveries accurately align with target mass concentrations.

Because lyophilized cakes vary by fill mass—commonly supplied in 10 mg, 30 mg, or 60 mg mass specifications—researchers must adjust diluent addition volume to achieve intended working concentrations. Exploring our full catalog of high-purity all peptides provides context on how lyophilized formatting maintains compound integrity prior to wet lab integration. When working specifically with high-capacity vials such as Semax 30mg, exact fluid volumetric metrics prevent concentration variances across operational assay plates.

The Master Peptide Reconstitution Formula

Determining the final concentration of a reconstituted peptide requires standard volumetric mass equations. The foundational relationship governing solution concentration is:

Concentration (mg/mL) = Total Peptide Mass (mg) / Total Diluent Volume (mL)

To calculate the mass present within a standard laboratory transfer aliquot (typically 0.1 mL or 100 µL, equivalent to 10 graduations on a standard 1 mL volumetric syringe), researchers apply the following sub-formula:

Mass per 0.1 mL Aliquot (mg) = Concentration (mg/mL) × 0.1 mL

To convert milligrams to micrograms for micro-dosing assays in cell cultures or rodent models, multiply the resulting milligram figure by 1,000 (1 mg = 1,000 µg). Researchers seeking rapid calculations across customized volumetric ratios can utilize our interactive reconstitution calculator to minimize manual arithmetic errors during protocol preparation.

Worked Reconstitution Examples for Common Vial Sizes

To illustrate the practical execution of these mathematical relationships, consider two standard laboratory scenarios utilizing different mass fill specifications and diluent volumes.

Example 1: Reconstituting a 10 mg Semax Vial with 2.0 mL Diluent. Target goal: Calculate mg/mL and µg per 0.1 mL aliquot. - Step 1: Calculate total concentration: 10 mg / 2.0 mL = 5.0 mg/mL. - Step 2: Calculate mass in 0.1 mL aliquot: 5.0 mg/mL × 0.1 mL = 0.5 mg (or 500 µg). - Step 3: Calculate mass in 0.01 mL (10 µL) micro-aliquot: 5.0 mg/mL × 0.01 mL = 0.05 mg (or 50 µg).

Example 2: Reconstituting a 30 mg Semax Vial with 3.0 mL Diluent. Target goal: Calculate mg/mL and µg per 0.1 mL aliquot. - Step 1: Calculate total concentration: 30 mg / 3.0 mL = 10.0 mg/mL. - Step 2: Calculate mass in 0.1 mL aliquot: 10.0 mg/mL × 0.1 mL = 1.0 mg (or 1,000 µg). - Step 3: Calculate mass in 0.01 mL (10 µL) micro-aliquot: 10.0 mg/mL × 0.01 mL = 0.1 mg (or 100 µg).

Comprehensive Semax Reconstitution Reference Table

The following master reference table details the resulting concentration (mg/mL), mass per 0.1 mL aliquot (100 µL), and mass per 0.01 mL micro-aliquot (10 µL) across standard vial masses (10 mg, 30 mg, 60 mg) and common diluent volumes (1.0 mL to 5.0 mL).

| Vial Mass | Diluent Volume | Final Concentration | Mass per 0.1 mL (100 µL) | Mass per 0.01 mL (10 µL) | | :--- | :--- | :--- | :--- | :--- | | 10 mg | 1.0 mL | 10.0 mg/mL | 1.0 mg (1,000 µg) | 0.1 mg (100 µg) | | 10 mg | 2.0 mL | 5.0 mg/mL | 0.5 mg (500 µg) | 0.05 mg (50 µg) | | 10 mg | 2.5 mL | 4.0 mg/mL | 0.4 mg (400 µg) | 0.04 mg (40 µg) | | 10 mg | 3.0 mL | 3.33 mg/mL | 0.333 mg (333 µg) | 0.033 mg (33.3 µg) | | 30 mg | 1.5 mL | 20.0 mg/mL | 2.0 mg (2,000 µg) | 0.2 mg (200 µg) | | 30 mg | 3.0 mL | 10.0 mg/mL | 1.0 mg (1,000 µg) | 0.1 mg (100 µg) | | 30 mg | 5.0 mL | 6.0 mg/mL | 0.6 mg (600 µg) | 0.06 mg (60 µg) | | 60 mg | 3.0 mL | 20.0 mg/mL | 2.0 mg (2,000 µg) | 0.2 mg (200 µg) | | 60 mg | 6.0 mL | 10.0 mg/mL | 1.0 mg (1,000 µg) | 0.1 mg (100 µg) | | 60 mg | 10.0 mL | 6.0 mg/mL | 0.6 mg (600 µg) | 0.06 mg (60 µg) |

Researchers should select diluent volumes based on the pipetting precision of their laboratory hardware and the specific solubility limits required for their in vitro or in vivo experimental models.

Comparative Analysis within the Synthetic Nootropic Class

In preclinical neurochemical and enzymatic research, Semax is frequently evaluated alongside structurally related synthetic peptides derived from endogenous regulatory fragments. Comparing reconstitution parameters across this class reveals critical considerations regarding molecular weight, aqueous solubility, and solvent compatibility.

When designing comparative research trials, investigators often evaluate Semax alongside Selank and modified acylated derivatives such as N-Acetyl Semax. While Semax (Met-Glu-His-Phe-Pro-Gly-Pro) exhibits high solubility in aqueous buffer systems up to 20 mg/mL, related compounds may demonstrate altered dissolution rates depending on hydrophobic modifications. For instance, researchers referencing our Selank reconstitution chart will note similar volumetric dynamics, though target molar concentrations must account for slight differences in molecular mass. Detailed mechanistic comparisons between these two regulatory heptapeptides can be explored in our technical breakdown of Semax vs Selank.

Selecting Appropriate Laboratory Diluents

The selection of diluent directly impacts the chemical stability, sterility, and shelf life of reconstituted Semax solutions. Depending on the intended analytical assay, laboratory personnel generally select between three primary solvent systems:

1. Bacteriostatic Water (0.9% Benzyl Alcohol): Recommended for multi-dose laboratory sampling protocols spanning extended research timelines. The presence of 0.9% benzyl alcohol inhibits microbial proliferation, extending liquid stability under refrigeration (2°C–8°C) for up to 28 days.

2. Sterile 0.9% Sodium Chloride (Normal Saline): Preferred for acute in vivo rodent research or cell culture assays sensitive to alcohol preservatives. Saline maintains isotonic equilibrium, though lacking preservatives requires immediate use or aliquot freezing.

3. Sterile Water for Injection (SWFI): Suitable for single-use analytical procedures, high-performance liquid chromatography (HPLC) mobile phase preparation, or mass spectrometry validation. Unpreserved solutions must be discarded after initial sampling to avoid microbial contamination.

Standard Operating Procedure for Aseptic Reconstitution

Maintaining peptide structural integrity during reconstitution requires strict adherence to aseptic handling protocols to prevent mechanical degradation or bacterial contamination.

Protocol Execution: - Step 1: Clean the laboratory workspace inside a laminar flow hood and sanitize the rubber stoppers of both the diluent container and the Semax vial using 70% isopropyl alcohol wipes. - Step 2: Draw the predetermined volume of diluent using a calibrated precision syringe equipped with a low-dead-space needle. - Step 3: Insert the needle through the center of the Semax vial stopper at a 45-degree angle. Equalize vial vacuum pressure if necessary. - Step 4: Direct the fluid stream down the interior glass wall of the vial rather than shooting directly onto the lyophilized cake to minimize mechanical shear stress. - Step 5: Allow the diluent to passively saturate the cake. Gently swirl the vial in a circular motion until fully dissolved. NEVER shake or vortex the vial vigorously, as high kinetic forces can disrupt fragile peptide bonds.

Verification of batch purity and identity should always precede reconstitution. Researchers can inspect lot-specific analytical documentation by requesting a verified Certificate of Analysis (COA) prior to assay execution.

Storage Parameters and Degradation Prevention

Lyophilized and reconstituted peptides exhibit distinct thermodynamic stability profiles. To prevent hydrolysis, oxidation, and aggregation, research facilities must adhere to strict temperature management:

- Lyophilized Storage: Unreconstituted Semax vials should be stored at -20°C for long-term stability (up to 24 months) or 2°C to 8°C for short-term handling (up to 90 days). Protect from light exposure. - Reconstituted Liquid Storage: Once dissolved in bacteriostatic water, store the vial at 2°C to 8°C. Solutions remain stable for up to 28 days under refrigerated conditions. Avoid repeated freeze-thaw cycles, which induce peptide cleavage and aggregate formation. - Freeze-Thaw Aliquoting: If long-term storage of reconstituted material is necessary without preservatives, split the liquid into single-use micro-centrifuge tubes and store at -80°C. Thaw each aliquot once immediately prior to assay execution.

Quality Assurance Standards at PX1 Research

The reliability of preclinical data depends entirely on the purity, consistency, and structural integrity of the research reagents utilized. PX1 Research supplies USA-manufactured research peptides synthesized under stringent quality controls in GMP-compliant facilities.

Every production lot undergoes rigorous analytical testing at an independent ISO 17025 accredited laboratory. Reagents are verified via High-Performance Liquid Chromatography (HPLC) to guarantee a minimum purity of 99%, while Mass Spectrometry (MS) confirms exact molecular weight identity. Furthermore, all batches undergo chromogenic LAL testing to ensure endotoxin levels remain strictly below regulatory thresholds (<0.05 EU/mg), preventing confounding inflammatory responses in sensitive cell lines or rodent models. Institutional buyers and laboratory directors looking to procure standardized reagents can establish commercial accounts through our wholesale program or review theoretical literature within our comprehensive research hub.